Beyond EMT, evaluation of AHR-regulated expression and activity patterns revealed several targets implicated in cancer progression, including members of the matrix metalloprotease family (MMPs, MMP9 and MMP24), asparagine synthetase (ASNS) and the ATF4 transcription factor. This evidence concerns the gene ATF4 and cancer.